> 数据图表一起讨论下4.7
2025-5-04.7CXO：推荐及受益标的盈利预测与估值表16：推荐及受益标的盈利预测与估值股票代码公司名称评级收盘价（元）EPSPE2025/4/302025E2026E2027E2025E2026E2027E603259.SH药明康德2269.HK药明生物2268.HK药明合联300759.SZ康龙化成300363.SZ博腾股份688621.SH阳光诺和300725.SZ药石科技300347.SZ泰格医药688076.SH诺泰生物买入买入买入买入买入买入买入买入买入002821.SZ凯莱英未评级59.1720.8833.4721.2215.0245.9732.1644.6152.9582.003.911.001.201.000.111.791.281.172.343.064.451.201.601.280.402.221.491.263.083.605.361.602.301.560.922.811.821.393.894.2515.120.927.921.2136.525.725.138.122.626.813.317.420.916.637.620.721.635.417.222.811.013.014.613.616.316.417.732.113.619.3CXO数据来源：Wind、开源证券研究所 注：数据截至2025年4月30日收盘；药明生物、药明合联收盘价以港元计，汇率选择1元=1.0774港元。 
